Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.3M Buy
1,862,314
+127,917
+7% +$3.41M 0.06% 251
2025
Q4
$43.2M Buy
1,734,397
+26,777
+2% +$675K 0.05% 286
2025
Q3
$43.5M Buy
1,707,620
+73,295
+4% +$1.81M 0.06% 268
2025
Q2
$39.6M Sell
1,634,325
-6,605
-0.4% -$154K 0.06% 277
2025
Q1
$41.6M Buy
1,640,930
+112,145
+7% +$2.93M 0.07% 243
2024
Q4
$40.6M Buy
1,528,785
+169,712
+12% +$4.6M 0.07% 240
2024
Q3
$39.3M Sell
1,359,073
-11,164
-0.8% -$326K 0.07% 242
2024
Q2
$38.3M Buy
1,370,237
+28,030
+2% +$772K 0.07% 227
2024
Q1
$37.2M Buy
1,342,207
+20,673
+2% +$574K 0.08% 224
2023
Q4
$38M Sell
1,321,534
-158,500
-11% -$4.79M 0.09% 209
2023
Q3
$49.1M Sell
1,480,034
-595,593
-29% -$21.1M 0.13% 150
2023
Q2
$76.1M Buy
2,075,627
+39,021
+2% +$1.52M 0.2% 103
2023
Q1
$83.1M Sell
2,036,606
-211,401
-9% -$9.13M 0.24% 90
2022
Q4
$115M Buy
2,248,007
+309,653
+16% +$14.8M 0.37% 64
2022
Q3
$84.8M Buy
1,938,354
+93,867
+5% +$4.56M 0.34% 71
2022
Q2
$96.7M Buy
1,844,487
+466,952
+34% +$23.8M 0.4% 65
2022
Q1
$71.3M Buy
1,377,535
+211,192
+18% +$11M 0.27% 88
2021
Q4
$68.9M Buy
1,166,343
+177,548
+18% +$8.8M 0.29% 88
2021
Q3
$42.5M Buy
988,795
+124,214
+14% +$5.5M 0.22% 120
2021
Q2
$33.9M Buy
864,581
+55,612
+7% +$2.16M 0.21% 130
2021
Q1
$29.3M Buy
808,969
+33,015
+4% +$1.17M 0.2% 136
2020
Q4
$28.6M Buy
775,954
+32,435
+4% +$1.19M 0.22% 127
2020
Q3
$25.9M Buy
743,519
+34,582
+5% +$1.21M 0.24% 111
2020
Q2
$22M Buy
708,937
+23,982
+4% +$815K 0.22% 124
2020
Q1
$21.2M Buy
684,955
+50,332
+8% +$1.72M 0.27% 111
2019
Q4
$23.6M Buy
634,623
+40,036
+7% +$1.43M 0.25% 119
2019
Q3
$20.3M Sell
594,587
-521,026
-47% -$18.9M 0.24% 116
2019
Q2
$45.9M Buy
1,115,613
+3,925
+0.4% +$156K 0.55% 48
2019
Q1
$34.7M Buy
1,111,688
+317,810
+40% +$12.7M 0.49% 54
2018
Q4
$32.8M Buy
793,878
+358,893
+83% +$14.9M 0.58% 42
2018
Q3
$18.2M Buy
434,985
+5,053
+1% +$195K 0.47% 50
2018
Q2
$14.8M Buy
429,932
+119,106
+38% +$4.07M 0.42% 55
2018
Q1
$10.5M Buy
310,826
+642
+0.2% +$22.1K 0.38% 61
2017
Q4
$10.7M Buy
310,184
+55,499
+22% +$1.89M 0.41% 55
2017
Q3
$8.63M Buy
254,685
+17,466
+7% +$561K 0.39% 55
2017
Q2
$7.56M Sell
237,219
-26,638
-10% -$840K 0.36% 59
2017
Q1
$8.56M Buy
263,857
+11,634
+5% +$367K 0.37% 57
2016
Q4
$7.77M Buy
252,223
+36,166
+17% +$1.1M 0.36% 59
2016
Q3
$6.94M Sell
216,057
-751
-0.3% -$25.1K 0.34% 54
2016
Q2
$7.24M Buy
216,808
+37,919
+21% +$1.21M 0.39% 51
2016
Q1
$5.03M Buy
178,889
+42,590
+31% +$1.22M 0.3% 66
2015
Q4
$4.17M Sell
136,299
-12,297
-8% -$387K 0.27% 83
2015
Q3
$4.43M Buy
148,596
+8,005
+6% +$257K 0.2% 115
2015
Q2
$4.47M Buy
140,591
+48,363
+52% +$1.58M 0.21% 112
2015
Q1
$3.04M Buy
92,228
+20,108
+28% +$639K 0.26% 71
2014
Q4
$2.13M Buy
72,120
+7,808
+12% +$224K 0.19% 97
2014
Q3
$1.8M Buy
64,312
+1,061
+2% +$29.8K 0.2% 91
2014
Q2
$1.78M Buy
63,251
+145
+0.2% +$4.13K 0.2% 98
2014
Q1
$1.92M Sell
63,106
-22,172
-26% -$661K 0.25% 86
2013
Q4
$2.48M Buy
85,278
+9,077
+12% +$264K 0.31% 71
2013
Q3
$2.08M Sell
76,201
-48,297
-39% -$1.31M 0.38% 66
2013
Q2
$3.31M Buy
+124,498
New +$3.44M 0.7% 39

Other funds holding PFE

Mariner's PFE Position: Q1 2026 in Review

Mariner increased its Pfizer (PFE) stake by 7.4% in Q1 2026, buying an estimated $3.41M and bringing the position to 1,862,314 shares worth $52.3M. The position accounts for 0.06% of the portfolio, ranked #251.

Mariner first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $115M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Mariner held 1,862,314 shares of Pfizer worth $52.3M as of Q1 2026.
  • Mariner bought 127,917 Pfizer shares in Q1 2026, an estimated $3.41M.
  • Pfizer made up 0.06% of Mariner's portfolio in Q1 2026, its #251 holding.
  • Mariner first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Mariner's Pfizer position peaked at $115M in Q4 2022.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.